肺炎克雷伯菌
大肠杆菌
耐碳青霉烯类肠杆菌科
医学
抗菌剂
肠杆菌科
生物
抗生素耐药性
DNA测序
微生物学
克雷伯菌感染
感染控制
公共卫生
碳青霉烯
疾病
疾病控制
基因组学
流行病学
病菌
公共卫生监督
欧洲联盟
病毒学
抗药性
环境卫生
作者
Sophia David,Anke Kohlenberg,Corin Yeats,Khalil Abudahab,Barbara Albiger,Nabil-Fareed Alikhan,Erik Alm,Sara Byfors,Natacha Couto,Julio Diaz Caballero,Christian G. Giske,Corinna Glasner,Marius Linkevičius,Erika Matuschek,Daniel Palm,Olov Svartström,Hajo Grundmann,Marc Jean Struelens,Karin Tegmark Wisell,Dominique L. Monnet
标识
DOI:10.1016/j.lanmic.2025.101321
摘要
Background The emergence of carbapenem resistance in Escherichia coli is of major concern due to the high propensity of spread of this species and scarce treatment options. Herein, we examined the occurrence and spread of carbapenem-resistant E coli based on the carbapenem-resistant and/or colistin-resistant Enterobacterales (CCRE) survey performed across European countries in 2019. Methods We analysed epidemiological, microbiological, and whole-genome sequencing data of 548 E coli isolates from individual patients from 156 hospitals in 32 European countries over 6 months in 2019. These hospitals collected the first ten successive isolates of carbapenem-resistant or carbapenem-susceptible increased exposure (carbapenem-R/I) Klebsiella pneumoniae species complex or E coli, and carbapenem-susceptible (carbapenem-S) comparator isolates of the same species. Antimicrobial susceptibility testing was performed for 19 antimicrobial agents. Whole-genome sequencing was performed centrally using Illumina technology. Isolates from the CCRE survey were compared with those from the European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) study. Findings Of the 548 E coli isolates, 211 (38·5%) were carbapenem-resistant or susceptible, increased exposure (carbapenem-R/I), and 337 (61·5%) were carbapenem-susceptible (carbapenem-S). Five sequence types (STs) accounted for 96 (45·5%) of 211 carbapenem-R/I isolates: ST131 (27), ST410 (20), ST38 (19), ST167 (16), and ST648 (14). Carbapenemase genes were identified in 182 (86·3%) carbapenem-R/I isolates, a pronounced increase from the 2013–14 EuSCAPE study (36 of 99, 36·4%). The most common genes were bla NDM−5 (62 of 182, 34·1%) and bla OXA−48 (40 of 182, 22·0%). bla NDM−5 carriage increased substantially compared with that in EuSCAPE (two of 99, 2·02%). Phylogenetic analysis showed substantial clonal spread of globally disseminated bla NDM−5 -harbouring lineages, with numerous introductions into Europe but minimal onward transmission. Interpretation High-risk STs of E coli carrying carbapenemase genes are rapidly spreading globally, although our results indicate that, in 2019, most cases in Europe were sporadic. We urge vigilant monitoring, including genomic surveillance, and strengthening of control efforts, to reduce mortality and morbidity associated with the impending rise in carbapenem-R/I E coli cases. Funding European Centre for Disease Prevention and Control and the Centre for Genomic Pathogen Surveillance.